Expression of p27Kip1 protein in gastric carcinoma

Hepato-Gastroenterology

Volumn 60, Issue 121, 2013, Pages 390-394

  Aoyagi, Keishiro ^a   Kouhuji, Kikuo ^a   Miyagi, Motoshi ^a   Imaizumi, Takuya ^a   Kizaki, Junya ^a   Isobe, Taro ^a   Shirouzu, Kazuo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric carcinoma; p27; p53

Indexed keywords

CELL NUCLEUS ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEIN P53;

ARTICLE; CANCER SURGERY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STOMACH CARCINOMA; SURVIVAL RATE;

CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; PROLIFERATING CELL NUCLEAR ANTIGEN; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84877744387     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge J: The p21 CdK-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75:805-816. (Pubitemid 23346377)
2. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366:701-704. (Pubitemid 24036020)
3. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994; 211:90-98. (Pubitemid 24167339)
4. Waga S, Hannon GJ, Beach D, Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994; 369:574-578. (Pubitemid 24192528)
5. Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge J, Reed SI: p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced Gl arrest. Cell 1994; 76:1013-1023. (Pubitemid 24106382)
6. Pines J, Hunter T: Cyclins and cancer II: cyclin D1 and CDK inhibitors come of age. Cell 1994; 79:573-582. (Pubitemid 24363801)
7. Sherr CJ: Mammalian G1 cyclins. Cell 1993; 73:1059-1065.
8. Del Sal G, Murphy M, Ruaro E, Lazarevic D, Levine AJ, Schneider C: Cyclin D1 and p21/waf1 are both involved in p53 growth suppression. Oncogene 1996; 12:177-185.
9. Murray AW, Kirschner MW: Dominoes and clocks: the union of two views of the cell cycle. Science 1989; 246:614-621. (Pubitemid 19283352)
10. Nurse P: Universal control mechanism regulating onset of M-phase. Nature 1990; 344:503-508.
11. Hengst L, Dulic V, Slingerland JM, Lees E, Reed SI: A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc Natl Acad Sci USA 1994; 91:5291-5295. (Pubitemid 24174312)
12. Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, Begg M, Wang S, Weinstein IB, Holt PR: Increased expression of cyclin D1 is an early event in multi stage colorectal carcinogenesis. Gastroenterology 1996; 110:669-674. (Pubitemid 26071834)
13. Jiang W, Zhang YJ, Kahn SM, Holistein MC, SantellaRM, Lu SH, Harris CC, Montesano R, Weinstein IB: Altered expression of cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 1993; 90:9026-9030. (Pubitemid 23306444)
14. Lee CC, Yamamoto S, Morimura K, Wanibuchi H, Nishisaka N, Ikemoto S, Nakatani T, Wada S, Kishimoto T: Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features. Cancer 1997; 79:780-789. (Pubitemid 27076344)
15. Itoi T, Shinohara Y, Takeda K, Nakamura K, Takei K, Sanada J, Horibe T, Saito T, Kasuya K, Ebihara Y: Nuclear cyclin D1 overexpression is a critical event associated with cell proliferation and invasive growth in gallbladder carcinogenesis. J Gastroenterol 2000; 35:142-149. (Pubitemid 30129006)
16. Akama Y, Yasui W, Yokozaki H, Kuniyasu H, Kitahara K, Ishikawa T, Tahara E: Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn J Cancer Res 1995; 86:617-621.
17. Nielsen NH, Arnerlov C, Emdin SO, Landberg G: Cyclin E overexpression: a negative prognostic factor in breast cancer with strong correlation to estrogen receptor status. Br J Cancer 1996; 74:874-880. (Pubitemid 26319319)
18. Nielsen NH, Emdin SO, Cajander J, Landberg G: Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene 1997 14:295-304. (Pubitemid 27073084)
19. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A: p27 Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest Genes Dev 994; 8:9-22.
20. Nakayama K, Nakayama K: Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development. Bioessays 1998; 20:1020-1029. (Pubitemid 29032180)
21. Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13:1501-1512. (Pubitemid 29297917)
22. Massague J: G1 cell-cycle control and cancer. Nature 2004; 432:298-306.
23. Toyoshima H, Hunter T: p27, a novel inhibitor of Gl cyclin-Cdk protein kinase activity, is related to p21. Cell 1994; 78:67-74. (Pubitemid 24228301)
24. Slingerland J, Pagano M: Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 2000; 183:10-17. (Pubitemid 30130220)
25. Nho RS, Sheaff RJ: p27kip1 contribution to cancer. Prog Cell Cycle Res 2003; 5:249-259.
26. Sherr CJ: D-type cyclins. Trends Biochem Sci 1995; 20:187-190.
27. Ioachim E, Peschos D, Goussia A, et al.: Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. J Exp Clin Cancer Res 2004; 23:277-283. (Pubitemid 38943560)
28. Gillet C, Fantl V, Smith R, et al.: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994; 54:1812-1817. (Pubitemid 24116192)
29. Youssef EM, Hasuma T, Morishima Y, et al.: Overexpression of cyclin D1 in rat esophageal carcinogenesis model. Jpn J Cancer Res 1997; 88:18-25. (Pubitemid 27096224)
30. Aoyagi K, Koufuji K, Yano S, et al.: Immunohistochemical study on the expression of cyclin D1 and E in gastric cancer. Kurume Med J 2000; 47:199-203.
31. Ding Q, Grammer JR, Nelson MA, et al.: p27 Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain. J Biol Chem 2005; 280:6802-6815. (Pubitemid 40341235)
32. Furihata M, Ohtsuki Y, Sonobe H, et al.: Prognostic significance of cyclin E and p53 protein overexpression in carcinoma of the renal pelvis and ureter. Br J Cancer 1998; 77:783-788. (Pubitemid 28077467)
33. Sakaguchi T, Watanabe A, Sawada H, et al.: Prognostic value of cyclin E and p53 expression in gastric carcinoma. Cancer 1998; 82:1238-1243. (Pubitemid 28155384)
34. Yasui W, Akama Y, Kuniyasu H, et al.: Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status. J Exp Ther Oncol 1996; 1:88-94.
35. Aoyagi K, Koufuji K, Yano S, et al.: The expression of p53, p21 and TGF β1 in gastric carcinoma. Kurume Med J 2003; 50:1-7. (Pubitemid 37010251)